BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32332923)

  • 21. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response.
    Salton M; Lerenthal Y; Wang SY; Chen DJ; Shiloh Y
    Cell Cycle; 2010 Apr; 9(8):1568-76. PubMed ID: 20421735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
    Younas N; Zafar S; Shafiq M; Noor A; Siegert A; Arora AS; Galkin A; Zafar A; Schmitz M; Stadelmann C; Andreoletti O; Ferrer I; Zerr I
    Acta Neuropathol; 2020 Sep; 140(3):317-339. PubMed ID: 32577828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
    He X; Zhang P
    Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Emerging Role of the RNA-Binding Protein SFPQ in Neuronal Function and Neurodegeneration.
    Lim YW; James D; Huang J; Lee M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
    Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
    J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
    Wei Z; Wang Y; Ma W; Xing W; Lu P; Shang Z; Li F; Li H; Wang Y
    RNA Biol; 2023 Jan; 20(1):359-367. PubMed ID: 37335045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.
    Moraya AI; Ali JL; Samadder P; Liang L; Morrison LC; Werbowetski-Ogilvie TE; Ogunsina M; Schweizer F; Arthur G; Nachtigal MW
    J Exp Clin Cancer Res; 2017 May; 36(1):67. PubMed ID: 28499442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
    Gambelli A; Nespolo A; Rampioni Vinciguerra GL; Pivetta E; Pellarin I; Nicoloso MS; Scapin C; Stefanatti L; Segatto I; Favero A; D'Andrea S; Mucignat MT; Bartoletti M; Lucia E; Schiappacassi M; Spessotto P; Canzonieri V; Giorda G; Puglisi F; Vecchione A; Belletti B; Sonego M; Baldassarre G
    EMBO Mol Med; 2024 May; 16(5):1162-1192. PubMed ID: 38658801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine Long Noncoding RNA Morrbid Contributes in the Regulation of NRAS Splicing in Hepatocytes In Vitro.
    Fefilova A; Melnikov P; Prikazchikova T; Abakumova T; Kurochkin I; Mazin PV; Ziganshin R; Sergeeva O; Zatsepin TS
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
    Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
    Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
    Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
    Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
    Kim CJ; Lee JW; Choi JJ; Choi HY; Park YA; Jeon HK; Sung CO; Song SY; Lee YY; Choi CH; Kim TJ; Lee JH; Kim BG; Bae DS
    Eur J Cancer; 2011 Apr; 47(6):918-25. PubMed ID: 21134740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development.
    Thomas-Jinu S; Gordon PM; Fielding T; Taylor R; Smith BN; Snowden V; Blanc E; Vance C; Topp S; Wong CH; Bielen H; Williams KL; McCann EP; Nicholson GA; Pan-Vazquez A; Fox AH; Bond CS; Talbot WS; Blair IP; Shaw CE; Houart C
    Neuron; 2017 Apr; 94(2):322-336.e5. PubMed ID: 28392072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability.
    Cosker KE; Fenstermacher SJ; Pazyra-Murphy MF; Elliott HL; Segal RA
    Nat Neurosci; 2016 May; 19(5):690-696. PubMed ID: 27019013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.
    Sun J; Cai X; Yung MM; Zhou W; Li J; Zhang Y; Li Z; Liu SS; Cheung ANY; Ngan HYS; Li Y; Dai Z; Kai Y; Tzatsos A; Peng W; Chan DW; Zhu W
    Oncogene; 2019 Jan; 38(4):564-580. PubMed ID: 30166592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.